
北美经颅磁刺激器市场预测至 2028 年 - COVID-19 影响和区域分析(按类型 [单脉冲 TMS 和重复 TMS (rTMS)]、年龄组(成人和儿童)和应用(研究、诊断和治疗) )
No. of Pages: 105 | Report Code: TIPRE00024823 | Category: Life Sciences
No. of Pages: 105 | Report Code: TIPRE00024823 | Category: Life Sciences
北美经颅磁刺激器(TMS)市场基于三个主要国家进行了分析——美国、加拿大和墨西哥。据估计,在预测期内,美国将在经颅磁刺激器(TMS)市场中占据最大份额。美国经颅磁刺激器 (TMS) 市场的预计增长归因于药品制造的增加,医疗设备制造商越来越多地采用先进的医疗包装技术预计将在预测期内推动市场的增长。< /p>
老年人群对神经调节的需求有所增加,因为由于合并症和潜在的免疫抑制,老年人群更容易遭受慢性疼痛。此外,预计患有 COVID-19 感染和慢性疼痛的人群的需求将会增长,这进一步导致免疫抑制,对免疫系统产生复杂的影响。另一方面,由于不同国家和州政府实施的封锁和旅行限制,COVID-19大流行严重影响了医疗器械行业的供应链。在此期间,医疗器械的有限生产被允许继续进行。然而,目前北美许多国家的COVID-19疫情在治疗流程、疫苗接种等方面正在趋于稳定。人们选择常规治疗,并按照要求到诊所和医院就诊。预计 COVID-19 大流行将在预测期内减缓北美经颅磁刺激器市场的整体增长。
北美经颅磁刺激器市场预计将从2021年的3.9816亿美元增长到2028年的7.311亿美元;预计2021年至2028年复合年增长率为9.1%。经颅磁刺激器(TMS)是一种非侵入性且耐受性良好的治疗方法,其过程不需要麻醉,属于门诊服务,患者可以继续治疗治疗后立即进行日常生活。 TMS 是一种创新且独特的精神治疗方法,受到精神科心理健康专业人员的青睐。因此,TMS 在世界范围内的接受度不断提高,导致产品的批准量不断增加。
北美经颅磁刺激器市场分为类型、年龄组、应用和国家。北美经颅磁刺激器市场根据类型分为单脉冲或成对脉冲TMS、重复TMS(rTMS)。 2020 年,单脉冲或成对脉冲 TMS 细分市场占据最大市场份额。北美经颅磁刺激器市场按年龄组分为成人和儿童。 2020 年,成人市场占据最大市场份额。北美经颅磁刺激器市场按应用划分,分为研究、诊断和治疗。 2020 年,诊断细分市场占据最大市场份额。按国家/地区划分,北美经颅磁刺激器市场分为美国、加拿大和墨西哥。美国在 2020 年占据最大的市场份额。
一些主要的一手和二手来源提到准备这份北美经颅磁刺激器市场报告的资料包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有 BrainsWay Ltd; eNeura 公司;磁力与更多有限公司;麦格斯蒂姆; MagVenture 公司;神经元学;神经软件; Nexstim;已修复;和 TMS 神经解决方案。
Strategic insights for North America Transcranial Magnetic Stimulator involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 398.16 Million |
Market Size by 2028 | US$ 731.10 Million |
Global CAGR (2021 - 2028) | 9.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Transcranial Magnetic Stimulator refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Transcranial Magnetic Stimulator Market is valued at US$ 398.16 Million in 2021, it is projected to reach US$ 731.10 Million by 2028.
As per our report North America Transcranial Magnetic Stimulator Market, the market size is valued at US$ 398.16 Million in 2021, projecting it to reach US$ 731.10 Million by 2028. This translates to a CAGR of approximately 9.1% during the forecast period.
The North America Transcranial Magnetic Stimulator Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Transcranial Magnetic Stimulator Market report:
The North America Transcranial Magnetic Stimulator Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Transcranial Magnetic Stimulator Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Transcranial Magnetic Stimulator Market value chain can benefit from the information contained in a comprehensive market report.